(USPH) US Physicalrapy - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90337L1089
USPH EPS (Earnings per Share)
USPH Revenue
USPH: Physical Therapy, Injury Prevention
U.S. Physical Therapy, Inc. is a healthcare services provider that operates and manages a network of outpatient physical therapy clinics across the United States. The companys business model is diversified across two main segments: Physical Therapy Operations, which provides a range of physical therapy services to patients, and Industrial Injury Prevention Services, which offers specialized injury prevention and rehabilitation programs to corporate clients, including Fortune 500 companies.
The companys Physical Therapy Operations segment provides pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, and neurological-related injuries, as well as preventative care and rehabilitation services for injured workers. The Industrial Injury Prevention Services segment leverages physical therapists and certified athletic trainers to deliver onsite injury prevention and rehabilitation programs, performance optimization services, and ergonomic assessments to clients.
With a strong presence in the US healthcare market, U.S. Physical Therapy, Inc. has established a reputation for delivering high-quality physical therapy services. The companys business model is designed to capitalize on the growing demand for outpatient physical therapy services, driven by an aging population and an increasing focus on preventive care. As the company continues to expand its operations, it is well-positioned to benefit from trends in the US healthcare market.
Based on the current technical and fundamental data, a forecast for USPH can be made. The stock is currently trading at $77.34, with a 20-day SMA of $76.53, indicating a slight uptrend. The 50-day SMA is $73.01, and the 200-day SMA is $81.87, suggesting that the stock is experiencing a correction after a previous uptrend. The ATR of 2.44 (3.15%) indicates moderate volatility. Given the companys strong fundamentals, including a market cap of $1.17 billion and a forward P/E ratio of 31.85, we can expect the stock to appreciate in the coming months. A potential price target could be $85, representing a 10% increase from current levels.
To support this forecast, we can analyze the companys historical performance and industry trends. USPH has a history of delivering consistent revenue growth, driven by its expanding network of physical therapy clinics and increasing demand for its industrial injury prevention services. The healthcare industry is expected to continue growing, driven by an aging population and an increasing focus on preventive care. As a leading player in the outpatient physical therapy market, USPH is well-positioned to benefit from these trends, making it a potentially attractive investment opportunity.
Additional Sources for USPH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
USPH Stock Overview
Market Cap in USD | 1,170m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1992-05-28 |
USPH Stock Ratings
Growth Rating | -19.7 |
Fundamental | 16.9 |
Dividend Rating | 65.5 |
Rel. Strength | -12.7 |
Analysts | 4.14 of 5 |
Fair Price Momentum | 67.70 USD |
Fair Price DCF | 79.20 USD |
USPH Dividends
Dividend Yield 12m | 2.26% |
Yield on Cost 5y | 2.52% |
Annual Growth 5y | 40.63% |
Payout Consistency | 92.0% |
Payout Ratio | 73.9% |
USPH Growth Ratios
Growth Correlation 3m | 69.2% |
Growth Correlation 12m | -63.8% |
Growth Correlation 5y | -28.2% |
CAGR 5y | 1.04% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | -1.58 |
Alpha | -27.14 |
Beta | 0.804 |
Volatility | 36.83% |
Current Volume | 213.1k |
Average Volume 20d | 162.8k |
As of June 23, 2025, the stock is trading at USD 74.28 with a total of 213,122 shares traded.
Over the past week, the price has changed by -3.96%, over one month by -0.89%, over three months by +1.46% and over the past year by -20.32%.
Neither. Based on ValueRay´s Fundamental Analyses, US Physicalrapy is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.85 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of USPH is around 67.70 USD . This means that USPH is currently overvalued and has a potential downside of -8.86%.
US Physicalrapy has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy USPH.
- Strong Buy: 2
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, USPH US Physicalrapy will be worth about 74.7 in June 2026. The stock is currently trading at 74.28. This means that the stock has a potential upside of +0.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 106 | 42.7% |
Analysts Target Price | 106 | 42.7% |
ValueRay Target Price | 74.7 | 0.5% |